World Hepatitis Day Initiatives
The World Hepatitis Alliance supports campaigners and patient organisations around the world to help make a difference to the lives of the millions of people living with viral hepatitis and to prevent new infections. To find out more on what is going on in your country, use the map below to find local organisations, World Hepatitis Day initiatives and other initiatives.
You can also look at our ‘Wall of Stories’ and submit your own personal experience of living with hepatitis or find other community resources including an Online Scrapbook and our latest Newsletters. The This is hepatitis... blog features bloggers from around the world talking about their experiences with hepatitis.




Name:
Org:
Country: Mexico
City: Ciudad de México
Type: WHD
Mexico - WHD 2011
The group Fundación Mexicana para la Salud Hepática together with Civitas Firma and other groups organised a comprehensive campaign around the slogan ‘Son 5 las hepatitis virales, conócelas, afróntalas, hazte la prueba’. This year’s campaign aimed to educate the population about each type of viral hepatitis. Additionally, the movement ‘Voces Frente a la Hepatitis C’ once again promoted early diagnosis and treatment of hepatitis C with a press conference.
A special issue of the magazine ‘Salud Pública’ with the theme ‘Viral Hepatitis’ focused on a report about the recognition of hepatitis C as a health problem in Mexico. Also, a scientific conference at the National Academy of Medicine reminded everyone about the importance of taking hepatitis into account in the design of public policies. Both events generated a great deal of media coverage.
On July 30th a patients forum about quality of life was held at the National Medical Centre and free hepatitis C tests were distributed. Patients were encouraged to pinpoint their address on a map of the metropolitan area of Mexico City in order to organise patient meetings according to their location. The event had participation from several public institution authorities, civil society and the pharmaceutical industry. 
